SIT AND DELIVER

12:54 25_05_DDL_SaD_Mendelsohn_1280x720
Treating Chronic Conditions Via Long-Acting Implants With Vivani's Adam Mendelsohn

The popular GLP-1 agonists employed in treating obesity and Type 2 diabetes are commonly administered via weekly injections. In this episode of Sit and Deliver, host Tom von Gunden talks with CEO Adam Mendelsohn of Vivani Medical about enhancing patient adherence and conv...

ABOUT SIT AND DELIVER

Created for stakeholders across the drug delivery landscape, from sponsor companies to regulatory agencies, Sit and Deliver offers timely insights from leading thinkers on drug delivery trends, movements, opportunities, and challenges.

FEATURED GUESTS

Adam Mendelsohn
CEO
PLAY
Jared Stanley
DeFloria
PLAY
Joel Stanley
DeFloria
PLAY
Steven Quay
Atossa Therapeutics
PLAY
Wim Souverijns
Pharvaris
PLAY
Stefan Abele
Pharvaris
PLAY
Thomas Heineman
Oncolytics Biotech
PLAY
Karl Thor
Dignify Therapeutics
PLAY
Bryan Mazlish
Surf Bio
PLAY
Nathan Givoni
Gelteq
PLAY
Matt D'Onofrio
Evoke Pharma
PLAY
Greg Sturmer
Elysium Therapeutics
PLAY
Rick Geoffrion
Cyrano Therapeutics
PLAY
John Weiner
FDA
PLAY
Stephen Marcus
Cantex
PLAY
Dinesh Patel
Protagonist Therapeutics
PLAY

MEET YOUR HOST

 

On each episode of Sit and Deliver, Drug Delivery Leader Chief Editor Tom von Gunden frames a topic of interest and impact to drug delivery professionals and invites a guest commentator to “deliver” perspectives on that focused topic.

Interested in joining Tom on an episode? Contact him today.